These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8032881)

  • 21. 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence cocaine-induced place conditioning.
    Hemby SE; Jones GH; Neill DB; Justice JB
    Behav Brain Res; 1992 Aug; 49(2):225-30. PubMed ID: 1388816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
    Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
    Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry.
    Sabol KE; Richards JB; Yung K
    J Pharmacol Exp Ther; 2000 Sep; 294(3):850-63. PubMed ID: 10945833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex.
    Shoblock JR; Maisonneuve IM; Glick SD
    Neurochem Res; 2004 Jul; 29(7):1437-42. PubMed ID: 15202777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired acquisition and operant responding after neonatal dopamine depletion in rats.
    Moy SS
    Pharmacol Biochem Behav; 1995 Oct; 52(2):433-41. PubMed ID: 8577812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
    Boyce PJ; Finlay JM
    Brain Res Dev Brain Res; 2005 May; 156(2):167-75. PubMed ID: 16099303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion.
    Lacroix L; Spinelli S; White W; Feldon J
    Neuroscience; 2000; 97(3):459-68. PubMed ID: 10828529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perseverative behavior in rats with methamphetamine-induced neurotoxicity.
    Son JH; Kuhn J; Keefe KA
    Neuropharmacology; 2013 Apr; 67():95-103. PubMed ID: 23159331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation.
    Cousins MS; Salamone JD
    Neuroscience; 1996 Feb; 70(4):849-59. PubMed ID: 8848171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of catecholamine innervation in the medial prefrontal cortex on the regulation of body weight and food intake.
    Gálosi R; Hajnal A; Petykó Z; Hartmann G; Karádi Z; Lénárd L
    Behav Brain Res; 2015 Jun; 286():318-27. PubMed ID: 25783808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats.
    Li CR; Huang GB; Sui ZY; Han EH; Chung YC
    Brain Res; 2010 Jul; 1346():183-9. PubMed ID: 20513371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in DRH and DRL performance in rats developmentally exposed to an environmental PCB mixture.
    Sable HJ; Powers BE; Wang VC; Widholm JJ; Schantz SL
    Neurotoxicol Teratol; 2006; 28(5):548-56. PubMed ID: 16930942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
    Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
    Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
    Tanda G; Ebbs AL; Kopajtic TA; Elias LM; Campbell BL; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2007 Apr; 321(1):334-44. PubMed ID: 17255465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement.
    Fletcher PJ
    Brain Res; 1995 Mar; 675(1-2):45-54. PubMed ID: 7540930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
    Chiang FK; Cheng RK; Liao RM
    Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.